This week Pfizer is set to announce its financial backing of the development of an embryonic stem cell therapy to cure age-related macular degeneration (AMD). The clinical trial would begin in about two years.
Read about it here.
Thinking about ethics and current events (Began 1 April 2008)
No comments:
Post a Comment